跳至主要内容
临床试验/KCT0007558
KCT0007558尚未招募未知

A Comparison of Mirtazapine and Benzodiazepine in Patients with Acute Anxiety: a Randomized Controlled Trial

Chung-Ang Univerisity Hospital0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 65(Year)(—)
性别
All

入选标准

  • ?the age between 18 and 65
  • ?people diagnosed with major depressive disorder without psychotic features by the Structured Clinical Interview for DSM-5 (SCID-5)
  • ?Beck Anxiety Inventory(BAI) scale score of 16 or higher (with moderate or severe anxiety symptoms)
  • ?based on the baseline, those who have no history of taking Mirtazapine or Benzodiazepine in the last 2 months
  • ?people who have been administered antidepressants(SSRI, SNRI, or NDRI) in stable doses for more than 1 month.

排除标准

  • ?people diagnosed with other psychiatric disorders by SCID-5-CV
  • ?People with severe medical conditions (cancer, heart failure, renal failure, liver disease, lung disease, thyroid disease, and acute inflammatory conditions)
  • ?people who have a history of substance dependence or misuse in the past or present
  • ?people with a history of epilepsy, head injury, or organic mental disorder

研究者

发起方
Chung-Ang Univerisity Hospital

相似试验